Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 09 2024
0mins
Should l Buy ?
Source: Benzinga
Helen of Troy Limited Earnings Report:
- Helen of Troy Limited (HELE) experienced a sharp decline in shares after reporting lower-than-expected first-quarter earnings and revising its FY25 guidance.
- Quarterly earnings were reported at 99 cents per share, missing the analyst consensus estimate of $1.59.
- Quarterly sales stood at $416.85 million, falling short of the analyst consensus estimate of $446.22 million.
- The stock price of Helen of Troy dropped by 30.3% to $62.06 following the news.
Stock Movements:
- Soligenix, Inc. (SNGX) saw a 195% increase in shares after announcing positive interim results for extended HyBryte treatment.
- uniQure N.V. (QURE) observed a 55.4% rise in shares due to updated interim data on AMT-130 for Huntington’s disease treatment.
- Various other companies like Pineapple Energy Inc., Anew Medical, Inc., Expensify, Inc., and more experienced significant stock movements, both positive and negative.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
